文献速递支持与姑息治疗

Apoyo con Cariño(关怀支持)试验:患者导航员干预改善拉丁裔晚期癌症成人姑息治疗结局的随机临床试验

Effect of Apoyo con Cariño (Support With Caring) Trial of a Patient Navigator Intervention to Improve Palliative Care Outcomes for Latino Adults With Advanced Cancer: A Randomized Clinical Trial.
PubMed 文献 · JAMA Oncol · 2018-01-01

该随机临床试验于2012年7月至2016年3月在科罗拉多州多个诊所开展,纳入223名自认拉丁裔的晚期癌症成人,评估文化定制患者导航员干预能否改善姑息治疗结局。干预组有预先医疗指示记录的比例高于对照组(65.2% vs 36.0%,P<.001),MQOL身体子量表评分变化优于对照组(1.4 vs 0.1,P=.004),但疼痛管理、临终关怀使用及总体生活质量无显著差异。

要点

  • 干预组预先医疗指示记录比例显著高于对照组(65.2% vs 36.0%,P<.001)。
  • MQOL身体子量表评分变化干预组显著优于对照组(1.4 vs 0.1,P=.004)。
  • 疼痛管理、临终关怀使用及总体生活质量两组无显著差异。

核心结论

  • 干预结果喜忧参半:增加了预先医疗计划并改善了身体症状,但对疼痛管理、临终关怀使用或总体生活质量无影响。
  • 需要进一步研究以确定非专业导航员在姑息治疗中的角色和范围。

研究设计与样本

  • Apoyo con Cariño(关怀支持)随机临床试验,2012年7月至2016年3月在科罗拉多州多个诊所开展,包括学术性国家癌症研究所指定癌症中心、社区癌症诊所(城市和农村)及安全网癌症中心。
  • 纳入223名自认拉丁裔且正在接受晚期癌症治疗的成人,平均(标准差)年龄58.1(13.6)岁,55.6%为女性,随机分为对照组(n=111)和干预组(n=112)。
  • 干预为文化定制患者导航员干预,采用意向性治疗设计。

主要发现

  • 干预组有预先医疗指示记录的患者比例高于对照组(73/112 [65.2%] vs 40/111 [36.0%],P<.001)。
  • 两组均报告轻度疼痛强度(疼痛评分均值3,0-10量表)。
  • 简明疼痛量表疼痛严重程度子量表(范围0-10)自基线变化均值(标准差)干预组为0.1(2.6),对照组为0.2(2.7)(P=.88);疼痛干扰子量表变化均值(标准差)干预组为0.1(3.2),对照组为-0.2(3.0)(P=.66)。
  • 两组临终关怀使用情况相似;MQOL总体评分及临终治疗侵袭性两组无显著差异。
  • MQOL身体子量表自基线变化均值(标准差)干预组为1.4(3.1),对照组为0.1(3.0)(P=.004)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 需要进一步研究以确定非专业导航员在姑息治疗中的角色和范围。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Strategies to increase access to palliative care, particularly for racial/ethnic minorities, must maximize primary palliative care and community-based models to meet the ever-growing need in a culturally sensitive and congruent manner. OBJECTIVE: To investigate if a culturally tailored patient navigator intervention can improve palliative care outcomes for Latino adults with advanced cancer. DESIGN, SETTING, AND PARTICIPANTS: The Apoyo con Cariño (Support With Caring) randomized clinical trial was conducted from July 2012 to March 2016. The setting was clinics across the state of Colorado, including an academic National Cancer Institute-designated cancer center, community cancer clinics (urban and rural), and a safety-net cancer center. Participants were adults who self-identified as Latino and were being treated for advanced cancer. INTERVENTION: Culturally tailored patient navigator intervention. MAIN OUTCOMES AND MEASURES: Primary outcome measures were advance care planning in the medical record, the Brief Pain Inventory, and hospice use. Secondary outcome measures included the McGill Quality of Life Questionnaire (MQOL), hospice length of stay, and aggressiveness of care at the end of life. This study used an intent-to-treat design. RESULTS: In total, 223 Latino adults enrolled (mean [SD] age, 58.1 [13.6] years; 55.6% female) and were randomized to control (n = 111) or intervention (n = 112) groups. Intervention group patients were more likely to have a documented advance directive compared with control group patients (73 of 112 [65.2%] vs 40 of 111 [36.0%], P < .001). Both groups reported mild pain intensity (mean pain rating of 3 on a scale of 0-10). Intervention group patients had a mean (SD) reported change from baseline in the Brief Pain Inventory pain severity subscale score (range, 0-10) of 0.1 (2.6) vs 0.2 (2.7) in control group patients (P = .88) and a mean (SD) reported change from baseline in the Brief Pain Inventory pain interference subscale score of 0.1 (3.2) vs -0.2 (3.0) in control group patients (P = .66). Hospice use was similar in both groups. Secondary outcomes of overall MQOL score and aggressiveness of care at the end of life showed no significant differences between groups. The MQOL physical subscale showed a mean (SD) significant change from baseline of 1.4 (3.1) in the intervention group vs 0.1 (3.0) in the control group (P = .004). CONCLUSIONS AND RELEVANCE: The intervention had mixed results. The intervention increased advance care planning and improved physical symptoms; however, it had no effect on pain management and hospice use or overall quality of life. Further research is needed to determine the role and scope of lay navigators in palliative care. TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT01695382.

来源:JAMA Oncol,查看原文。版权归原作者所有。

引用

  1. Fischer SM, Kline DM, Min SJ, et al. Effect of Apoyo con Cariño (Support With Caring) Trial of a Patient Navigator Intervention to Improve Palliative Care Outcomes for Latino Adults With Advanced Cancer: A Randomized Clinical Trial. JAMA Oncol. 2018. PMID: 30326035. doi:10.1001/jamaoncol.2018.4014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。